[Clinical evaluation of the use of somatostatin (VAL 787) in the treatment of upper digestive hemorrhage].
Personal experience with 30 patients treated with Somatostatin for upper gastrointestinal bleeding is reported. The conclusion is drawn that this drug, reducing chloro-peptic secretion and hepatic portal blood flow, can reduce and control bleeding and postpone the surgical operation, which has a high rate of mortality.
Dal Monte
P R
PR
D'Imperio
N
N
Formica
G
G
Macchia
S
S
Piemontese
A
A
Sarti
F
F
Spongano
P
P
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D004381:Duodenal Ulcer / Q000150:complications; D004932:Esophageal and Gastric Varices / Q000150:complications; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010438:Peptic Ulcer Hemorrhage / Q000188:drug therapy / Q000209:etiology; D013004:Somatostatin / Q000008:administration & dosage / Q000627:therapeutic use*; D013276:Stomach Ulcer / Q000150:complications; D013997:Time Factors
D013004:Somatostatin
Valutazione clinica dell'uso della somatostatina (VAL 787) nel trattamento delle emorragie digestive superiori.